According to a recent study in the Journal of the American Medical Association, roughly 12% of Americans have used GLP-1 drugs, even if unaffordable. The new Smoothie King menu is to support people taking these medicines
Ria Shirsolkar, MD, MS , provides a safe and personalized solution for long-term results
By sharing experiences and outcomes, we can collectively shape a healthier future
It's a formidable, often-unseen barrier to progress
As the NAC regimen (with an iv -priming dose) was more intense in severe than moderate IPTB cases, it is unclear whether differences are due to disease severity or to NAC treatment per se
As always, please reach out if you have questions